Massive Transfusion Protocols for Patients With Substantial Hemorrhage

Transfusion Medicine Reviews

Volumn 25, Issue 4, 2011, Pages 293-303

  Young, Pampee P ^a,b,c,d,e   Cotton, Bryan A ^a,b,c,d,e   Goodnough, Lawrence T ^a,b,c,d,e  

^a Dept of Pathology ^*  (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BLOOD; BLOOD CLOTTING; BLOOD COMPONENT; BLOOD TRANSFUSION; CELL THERAPY; CLINICAL PROTOCOL; CRYSTALLOID; ERYTHROCYTE; HYPOTENSION; MASSIVE TRANSFUSION PROTOCOL; RESUSCITATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ACADEMIC MEDICAL CENTERS; ALGORITHMS; BLOOD BANKS; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; CLINICAL PROTOCOLS; COHORT STUDIES; FACTOR VIII; FIBRINOGEN; FORECASTING; HEMORRHAGE; HUMANS; MILITARY MEDICINE; ORGANIZATIONAL POLICY; PRESCRIPTIONS; RESUSCITATION; SHOCK, HEMORRHAGIC; SURGERY DEPARTMENT, HOSPITAL; TRAUMA CENTERS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 80052519077     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.04.002     Document Type: Article

References (62)

1. Kauvar D.S., Lefering R., Wade C.E. Impact of hemorrhage on trauma outcome: An overview of epidemiology, clinical presentations and therapeutic considerations. J Trauma 2006, 60(6 suppl):S3-S11.
2. Acosta J.A., Yang J.C., Winchell R.J., et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998, 186:528-533.
3. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: A reassessment. J Trauma 1995, 185-193.
4. Trowbridge C., Stammers A., Klayman M., et al. Characteristics of uncontrolled hemorrhage in cardiac surgery. J Extra Corpor Technol 2008, 40:89-93.
5. Rose A.H., Kotze A., Doolan D., et al. Massive transfusion-evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern England. Vox Sang 2009, 97:247-253.
6. Holcomb J.B., Jenkins D., Rhee P., et al. Damage control resuscitation: Directly addressing the early coagulopathy of trauma. J Trauma 2007, 62:307-310.
7. Burtelow M., Riley E., Druzin M., et al. How we treat: Management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007, 47:1564-1572.
8. Barnert J., Messmann H. Medscape: Diagnosis and management of lower gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol 2009, 6:637-646.
9. Spinella P.C., Holcomb J.B. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009, 23:231-240.
10. Geeraedts L.M., Demiral H., Schaap N.P., et al. "Blind" transfusion of blood products in exsanguinating trauma patients. Resuscitation 2007, 73:382-388.
11. Cotton B.A., Dossett L.A., Au B.K., et al. Room for performance improvement: Provider-related factors associated with poor outcomes in massive transfusion. J Trauma 2009, 67:1004-1012.
12. Kowalenko T., Stern S., Dronen S., et al. Improved outcome with hypotensive resuscitation of uncontrolled hemorrhagic shock in a swine model. J Trauma 1992, 33:349-353.
13. Balogh Z., McKinley B.A., Holcomb J.B., et al. Both primary and secondary abdominal compartment syndrome can be predicted early and are harbingers of multiple organ failure. J Trauma 2003, 54:848-859.
14. Joshi G.P. Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anaesth Analg 2005, 101:601-605.
15. Borgman M.A., Spinella P.C., Perkins J.G., et al. The ratio of blood products transfused effects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
16. Como J.J., Dutton R.P., Scalea T.M., et al. Blood transfusion rates in the care of acute trauma. Transfusion 2004, 44:809-813.
17. Moore F.A., Nelson T., McKinley B.A., et al. Massive transfusion in trauma patients: Tissue hemoglobin oxygen saturation predicts poor outcome. J Trauma 2008, 64:1010-1023.
18. Niles S.E., McLaughlin D.F., Perkins J.G., et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma 2008, 64:1459-1463.
19. Brohi K., Singh J., Heron M., et al. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
20. Maegele M., Lefering R., Yucel N., et al. Early coagulopathy in multiple injury: An analysis of the German Trauma Registry on 8724 patients. Injury 2007, 38:298-304.
21. Stinger H.K., Spinella P.C., Perkins J.G., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 24(suppl):S79-S85.
22. Sihler K.C., Napolitano L.M. Complications of massive transfusion. Chest 2010, 137:209-220.
23. Norda R., Tynell E., Akerblom O. Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe. J Trauma 2006, 60(6 suppl):S41-S45.
24. Schreiber M.A., Perkins J.G., Kiraly L., et al. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 2007, 64:541-545.
25. Riskin D.J., Tsai T.C., Riskin L., et al. Massive transfusion protocols: The role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009, 209:198-203.
26. Zielinski M., Park M.S., Jenkins D. Appropriate evidence-based practice guidelines for plasma transfusion would include a high ratio of plasma to red blood cells based on the available data. Transfusion 2010, 50:2762-2764.
27. Dunne J.R., Riddle M.S., Danko J.H., et al. Blood transfusion is associated with infection and increased resource utilization in combat casualties. Am Surg 2006, 72:619-625.
28. Vamvakas EC. Platelet transfusion and postoperative infection in cardiac surgery. Transfusion 47: 352-354 (letter); author reply 354-356, 2007.
29. Sarani B., Dunkman W.J., Dean L., et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008, 36:1114-1118.
30. Moore F.A., Sauaia A., Moore E.E., et al. Postinjury multiple organ failure: A bimodal phenomenon. J Trauma 1996, 40:501-510.
31. Moore F.A., Moore E.E., Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997, 132:620-624.
32. Vamvakas E.C., Carven J.H. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells. Transfusion 1999, 39:701-710.
33. Cotton B.A., Gunter O.L., Isbell J., et al. Damage control hematology: The impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008, 64:1177-1183.
34. O'Keefe T., Refaai M., Tchorz K., et al. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008, 143:686-690.
35. Cotton B.A., Au B.K., Nunez T.C., et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009, 66:41-48.
36. Malone D.L., Hess J.R., Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006, 60(6 suppl):S91-S96.
37. Gunter O.L., Au B.K., Isbell J.M., et al. Optimizing outcomes in damage control resuscitation: Identifying blood product ratios associated with improved survival. J Trauma 2007, 65:527-534.
38. Schuster K.M., Davis K.A., Lui F.Y., et al. The status of massive tranfsuion protocols in the United States trauma centers: Massive transfusion or massive confusion. Transfusion 2010, 50:1545-1551.
39. Stansbury L.G., Dutton R.P., Stein D.M., et al. Controversy in trauma resuscitation: Do ratios of plasma to red blood cells matter?. Transfus Med Rev 2009, 23:255-265.
40. Hess J.R., Zimrin A.B. Massive blood transfusion for trauma. Curr Opin Hematol 2005, 12:488-492.
41. Hess J.R., Holcomb J.B., Hoyt D.B. Damage control resuscitation: The need for specific blood products to treat the coagulopathy of trauma. Transfusion 2006, 46:685-686.
42. Dutton R.P., Carson J.L. Indications for early red blood cell transfusion. J Trauma 2006, 60(6 suppl):S35-S40.
43. Ketchum L., Hess J.R., Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate and platelet transfusion in trauma. J Trauma 2006, 60(6 suppl):S1-S58.
44. Hirshberg A., Dugas M., Banez E.I., et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: A computer simulation. J Trauma 2003, 54:454-463.
45. Callum J.L., Nascimento B., Tien H., et al. Editorial: "Formula-driven" versus "lab-driven" massive transfusion protocols: At the state of clinical equipoise. Transfus Med Rev 2009, 23:247-254.
46. Kashuk J.L., Moore E.E., Johnson J.L., et al. Postinjury life threatening coagulopathy: Is 1:1 fresh frozen plasma: Packed red blood cells the answer?. J Trauma 2008, 65:261-271.
47. Shaz B.H., Dente C.J., Nicholas J.M., et al. Increased number of coagulation products in relationship to red blood cell products transfused imporves mortality in trauma patients. Transfusion 2010, 50:493-500.
48. Sperry J.L., Ochoa J.B., Gunn S.R., et al. FFP:PRBC transfusion ratio >1:1.5 is associated with lower risk of mortality after massive transfusion. J Trauma 2008, 65:986-993.
49. Dente C.J., Shaz B.H., Nicholas J.M., et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009, 66:1616-1624.
50. Johansson P.I., Stensballe J., Rosenberg I., et al. Proactive adminstration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: Evaluating a change in transfusion practice. Transfusion 2007, 47:593-598.
51. Snyder C.W., Weinberg J.A., McGwin G., et al. The relationship of blood product ratio to mortality: Survival benefit or survival bias?. J Trauma 2009, 66:358-362.
52. Duchesne J.C., Kimonis K., Marr A.B., et al. Damage control resuscitation in combination with damage control laparotomy: A survival advantage. J Trauma 2010, 69:46-52.
53. Johansson P.I. Hemostatic strategies for minimizing mortality in surgery with major blood loss. Curr Opin Hematol 2009, 16:509-514.
54. Hoyt D.B., Dutton R.P., Hauser C.J., et al. Management of coagulopathy in the patients with multiple injuries: Results from an international survey of clinical practice. J Trauma 2008, 65:755-764.
55. Spinella P.C. Warm fresh whole blood transfusion for severe hemorrhage: US military and potential civilian applications. Crit Care Med 2008, 36(7 suppl):S340-S345.
56. Spinella P.C., Perkins J.G., Grathwohl K.W., et al. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med 2007, 35:2576-2581.
57. Spinella P.C., Perkins J.G., Grathwohl K.W., et al. Warm fresh blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009, 66(4 suppl):S69-S76.
58. Perkins J.G., Cap A.P., Weiss B.M., et al. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med 2008, 36(7 suppl):S325-S339.
59. Sihler K.C., Napolitano L.M. Massive transfusion: New insights. Chest 2009, 136:1654-1667.
60. Woodruff S.I., Dougherty A.L., Dye J.L., et al. Use of recombinant factor VIIA for control of combat-related haemorrhage. Emerg Med 2010, 27:121-124.
61. Novonordisk: Evaluation of recombinant factor VIIa in patients with severe bleeding (control). Available at: :. http://clinicaltrials.gov/ct2/show/results/nct00184548.
62. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH 2): A randomized, placebo-controlled trial. Lancet 2010, 376:23-32. CRASH-2 Collaborators.